Posted on April 27, 2019


ACTG A randomized treatment-naive individuals to tenofovir-emtricitabine ( TDF/FTC) or abacavir-lamivudine (ABC/3TC) combined with efavirenz (EFV) or. This article reviews some of the differences in initial therapies for HIV infection. ACTG Shows Abacavir/lamivudine and Tenofovir/emtricitabine Provide Similar HIV Suppression at Low Viral Loads.

Author: Mazukinos Ner
Country: Lesotho
Language: English (Spanish)
Genre: Love
Published (Last): 6 February 2009
Pages: 282
PDF File Size: 18.32 Mb
ePub File Size: 16.55 Mb
ISBN: 915-7-11252-370-8
Downloads: 95250
Price: Free* [*Free Regsitration Required]
Uploader: Mohn

We did not separately assess the relationship between week 4 virologic response and early or late virologic failure. Struggling With Crystal Meth?

Participants were also stratified into two groups: Is atazanavir-ritonavir equivalent to efavirenz when used xctg combination with either Kivexa or Truvada? Journal of acquired immune deficiency syndromes Sep; 55 1: Most viral-dynamics models assume that ART results in complete inhibition of viral replication.

First-line ART – ACTG A Study

A post-hoc analysis, which could retrospectively exclude patients with HSR, has not yet been done. Thus, a comparison of early virologic response between different antiretroviral regimens may provide insights into a regimen’s inherent antiviral activity, although antiretrovirals targeting different steps in the viral replication cycle may sctg in different decay rates independent of their antiviral activity.

Dating, relationships and feelings Contraception Sexually transmitted infections epidemiology Sexually transmitted infections prevention Sexually transmitted infections treatment Sexually transmitted infections.

Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitor.

Daar E et al. When participants’ regimens failed, people taking efavirenz-based regimens were likely to develop HIV that could resist the effect of efavirenz or nukes, compared to atazanavir-based regimens. HIV treatment outcomes continue to get better, says large analysis 27 December All people with HIV-2 should receive HIV treatment — without it, most will progress to AIDS and death 27 November Early HIV treatment reduces the risk of liver fibrosis 08 November Dolutegravir or lower-dose efavirenz equally effective, but less resistance with dolutegravir 01 November NAM Publications Registered office: Study Details The average profile of participants at the start of the study was as follows: Secondly, the difference between anticipated and actual study outcomes made the definition of equivalence more demanding than originally intended.


Italian study shows growth in heart and kidney problems in people living with HIV 28 December There are several potential choices when it comes to the initial treatment of HIV infection. Talk to your doctor or another member of your healthcare team for advice tailored to your situation. The information provided through TheBody should not be used for diagnosing or treating a health problem or a disease.

The primary efficacy endpoint was time from randomization to virologic failure. In summary, we have shown that smaller four-week decline in viral load was associated with a higher rate of subsequent virologic failure. All Rights Reserved TheBody: Conclusions Within all treatment arms, a less robust week 4 virologic response was associated with higher risk for subsequent virologic failure. Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: We compared the viral load changes from entry to values obtained at Weeks 1, 2, and 4 between each of the four regimens using Wilcoxon rank sum tests.

Further information You can view the abstract on the official conference website. NAM recommends checking whether this is the most current information when making decisions that may affect your health. In the first place, an equivalence comparison is more stringent than the “non-inferiority” comparison commonly used in antiretroviral clinical trials.

Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202

Short factsheets, providing a summary of key topics. It may have been superseded by more recent developments. Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: In this protocol-specified secondary analysis of ACTG A and its viral load substudy, we found no significant difference in early viral load change between the NRTI arms, including in the high viral load stratum.


Conclusions — Comparing Atazanavir and Efavirenz Here are some of the conclusions that the ACTG team arrived at when comparing atazanavir-ritonavir to efavirenz: Support Center Support Center. HIV treatment outcomes continue to get better, says large analysis 27 December Patterns of viral load changes in the early viral load substudy mirrored the patterns observed in the overall study.

SaxMD, 4 Ann C.

Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A

A long life with HIV. Supporting sexual health and relationships for people with learning disabilities Behind the scenes at European Testing Week Coming soon: Data from this point in the study comparisons of the two nucleoside combinations for patients with high viral loadshave been presented and widely circulated.

See, however, acrg discussion of equivalence, below. All subjects provided written informed consent prior to study entry.

Acth can also view a webcast and slides of this session on the official conference website. Reference Daar E et al.

The chronic phase of untreated HIV actb is characterized by viral replication resulting in a dynamic equilibrium between viral production and clearance, with approximately one-half of the circulating virus replaced daily with newly produced virus.